Aisling Capital Management LP — 13F Holdings & Portfolio

CIK 1766721 · latest 13F-HR filed 2026-11-12

Aisling Capital Management LP manages $299.3M in 13F-reported U.S. long-equity assets across 14 reported positions as of its 2026-09-30 13F-HR filing. Its largest disclosed positions are BBIO (67.92%), SNDX (8.27%), CMPS (7.20%). Quarter over quarter (versus its 2026-06-30 filing) the fund opened 0 new positions and exited 0; 3 existing positions rose in reported value and 9 fell.

AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.

Loading holdings…
AUM
$299.3M

Long-equity book

Holdings
14

Distinct positions

Period
2026-09-30

Filed 2026-11-12

Q/Q Activity
+0 / −0 / ↑3 / ↓9

vs 2026-06-30

Portfolio charts

Latest quarter's book, what changed, and how the portfolio has evolved across filings.

Portfolio map

Q3 26

Box size = position value; colour = change in share count vs the prior quarter (green added, red trimmed, blue new). Rows split across managers or share classes are combined. Click a box for the stock.

Sector mix

% of 13F value

Sectors from each company's SIC code; funds and ETFs grouped separately.

Biggest buys and sells

Q2 26 → Q3 26

Estimated from the change in shares held × the quarter-end price, so price moves alone don't count as buying. New and exited positions are included.

13F assets and positions

4 quarters

Total reported 13F value (bars) and number of positions (line) each quarter. Value changes include market moves.

Top positions over time

reported value

The eight largest current positions, valued at each quarter end.

Concentration

top 10 = 98.5%

Cumulative share of the portfolio held in the largest N positions.

Firm Profile & Key People

As of the firm’s regulatory filing dated Mar 27, 2026.

Assets Under Management
$716.4M
Discretionary
$716.4M
Employees
12
Accounts
2
Address
489 FIFTH AVENUE
10TH FLOOR
NEW YORK, NY 10017
Phone
(212) 651-6380
Name Title / Status Ownership Type
AISLING CAPITAL PARTNERS IV LLC ControlGENERAL PARTNER
since Aug 2015
Less than 5%Domestic Entity
ELMS, STEVEN, ARNOTE ControlCO-PRESIDENT
since Aug 2015
50–75%Individual
SCHIFF, ANDREW, NEWMAN ControlCO-PRESIDENT
since Aug 2015
50–75%Individual
WENZEL, ROBERT, JOHN ControlCHIEF COMPLIANCE OFFICER / CHIEF FINANCIAL OFFICER
since Apr 2017
Less than 5%Individual
ELMS, STEVEN, ARNOTE Control
Indirect owner via AISLING CAPITAL PARTNERS IV LLC
MEMBER
since Aug 2015
50–75%Individual
SCHIFF, ANDREW, NEWMAN Control
Indirect owner via AISLING CAPITAL PARTNERS IV LLC
MEMBER
since Aug 2015
50–75%Individual
Ownership & leadership changes · 5 filings with changes since Aug 31, 2015

From the firm’s regulatory filings, newest first. Dates are filing dates: a filing that no longer lists someone does not say when they left.

Mar 28, 2018 filing
  • ChangedWENZEL, ROBERT, JOHN · title CHIEF COMPLIANCE OFFICER / CONTROLLER → CHIEF COMPLIANCE OFFICER / CHIEF FINANCIAL OFFICER
Apr 21, 2017 filing
  • No longer listedAPPEL, LLOYD, ERIC · CHIEF FINANCIAL OFFICER / TREASURER / CHIEF COMPLIANCE OFFICER · Less than 5% · control person · listed since Aug 2015
  • ChangedWENZEL, ROBERT, JOHN · title OFFICER / CONTROLLER → CHIEF COMPLIANCE OFFICER / CONTROLLER
Mar 22, 2017 filing
  • ChangedWENZEL, ROBERT, JOHN · title SECRETARY / CONTROLLER → OFFICER / CONTROLLER
Sep 14, 2015 filing
  • ChangedELMS, STEVEN, ARNOTE · indirect via AISLING CAPITAL PARTNERS IV LLC: title CO-OWNER → MEMBER
  • ChangedSCHIFF, ANDREW, NEWMAN · indirect via AISLING CAPITAL PARTNERS IV LLC: title CO-OWNER → MEMBER
Sep 11, 2015 filing
  • AddedELMS, STEVEN, ARNOTE · CO-OWNER · 50–75% · indirect via AISLING CAPITAL PARTNERS IV LLC · control person
  • AddedSCHIFF, ANDREW, NEWMAN · CO-OWNER · 50–75% · indirect via AISLING CAPITAL PARTNERS IV LLC · control person
Aug 31, 2015 filing (earliest on record)
  • ListedAISLING CAPITAL PARTNERS IV LLC · GENERAL PARTNER · Less than 5% · control person
  • ListedAPPEL, LLOYD, ERIC · CHIEF FINANCIAL OFFICER / TREASURER / CHIEF COMPLIANCE OFFICER · Less than 5% · control person
  • ListedELMS, STEVEN, ARNOTE · CO-PRESIDENT · 50–75% · control person
  • ListedSCHIFF, ANDREW, NEWMAN · CO-PRESIDENT · 50–75% · control person
  • ListedWENZEL, ROBERT, JOHN · SECRETARY / CONTROLLER · Less than 5% · control person

Quarter-over-quarter changes

Changes in reported position value vs the prior 13F, so price moves count too, not just shares bought or sold.

Top Adds (vs prior quarter)

Show all 3 →

New Positions

  • No new positions this quarter.
Show all 0 →

Exited Positions

  • No exits this quarter.
Show all 0 →

Aisling Capital Management LP Holdings (2026-09-30)

Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).

# Issuer Symbol CUSIP Value Weight Shares Type
1 BRIDGEBIO PHARMA INC BBIO 10806X102 $203.3M 67.92% 3,089,611 SH
2 SYNDAX PHARMACEUTICALS INC SNDX 87164F105 $24.8M 8.27% 1,316,806 SH
3 COMPASS PATHWAYS PLC CMPS 20451W101 $21.6M 7.20% 1,732,336 SH
4 MONTE ROSA THERAPEUTICS INC GLUE 61225M102 $18.6M 6.20% 1,555,664 SH
5 BICARA THERAPEUTICS INC BCAX 055477103 $10.2M 3.41% 548,919 SH
6 UROGEN PHARMA LTD URGN M96088105 $4.4M 1.47% 108,000 SH
7 BRIDGEBIO ONCOLOGY THERAPEUT BBOT 107924102 $4.1M 1.38% 1,018,018 SH
8 EUPRAXIA PHARMACEUTICALS INC EPRX 29842P105 $3.0M 0.99% 325,000 SH
9 BIOMEA FUSION INC BMEA 09077A106 $2.7M 0.92% 2,048,757 SH
10 ACLARIS THERAPEUTICS INC ACRS 00461U105 $2.3M 0.76% 434,455 SH
11 SCHOLAR ROCK HLDG CORP SRRK 80706P103 $2.0M 0.68% 42,031 SH
12 VTV THERAPEUTICS INC VTVT 918385204 $1.8M 0.61% 58,775 SH
13 MARKER THERAPEUTICS INC MRKR 57055L206 $348.1K 0.12% 325,370 SH
14 ONKURE THERAPEUTICS INC OKUR 68277Q105 $241.5K 0.08% 88,607 SH
Filing History
Period Filed AUM Holdings Accession
2026-09-30 2026-11-12 $299.3M 14 0001766721-26-000004
2026-06-30 2026-08-13 $471.6M 14 0001766721-26-000003
2026-03-31 2026-05-05 $476.3M 13 0001766721-26-000002
2025-12-31 2026-02-10 $478.9M 13 0001766721-26-000001
Filer Information
Address
489 5TH AVE, 10TH FLOOR
NEW YORK, NY 10017
Phone
(212) 651-6380
Filing Manager
Aisling Capital Management LP
NEW YORK, NY
Signatory
ROBERT J. WENZEL
CHIEF FINANCIAL OFFICER